Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 448 followers
Latest posts
Last updated about 10 hours ago
Human medicines European public assessment report (EPAR): Onureg, azacitidine, Date of authorisation: 17/06/2021, Revision: 5, Status: Authorised
about 10 hours ago
Human medicines European public assessment report (EPAR): Onureg, azacitidine, Date of authorisation...
Sponsor guidance: New safety module on the annual safety report
about 10 hours ago
Sponsor guidance: New safety module on the annual safety report
Herbal medicinal product: Fragariae folium, Fragaria vesca L., Fragaria moschata Weston,Fragaria viridis Weston,Fragaria x ananassa (Weston) Duchesne ex Rozier , F: Assessment finalised
about 11 hours ago
Herbal medicinal product: Fragariae folium, Fragaria vesca L., Fragaria moschata Weston,Fragaria viridis...
Human medicines European public assessment report (EPAR): Velsipity, etrasimod, Date of authorisation: 16/02/2024, Revision: 4, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Velsipity, etrasimod, Date of authorisation...
Human medicines European public assessment report (EPAR): Pomalidomide Krka, pomalidomide, Date of authorisation: 24/07/2024, Revision: 3, Status: Authorised
about 11 hours ago
Human medicines European public assessment report (EPAR): Pomalidomide Krka, pomalidomide, Date of...
Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Mylan, emtricitabine,tenofovir disoproxil, Date of authorisation: 16/12/2016, Revision: 19, Status: Authorised
about 12 hours ago
Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Mylan, emtricitabine,tenofovir disoproxil...
Human medicines European public assessment report (EPAR): Ambrisentan Viatris (previously Ambrisentan Mylan), ambrisentan, Date of authorisation: 20/06/2019, Revision: 10, Status: Authorised
about 13 hours ago
Human medicines European public assessment report (EPAR): Ambrisentan Viatris (previously Ambrisentan Mylan)...
Minutes of PRAC meeting on 8-11 June 2026
about 16 hours ago
Minutes of PRAC meeting on 8-11 June 2026